OOIR: Observatory of International Research

Papers

(The TQCC of Heart Failure Clinics is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Heart Failure with Preserved Ejection Fraction	54
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure	32
Unusual Forms of Pulmonary Hypertension	27
Tafamidis in the Treatment of ATTR-related Cardiomyopathy	26
Contents	24
Exercise Intolerance in Heart Failure with Preserved Ejection Fraction	24
Treatment of Advanced Heart Failure—Focus on Transplantation and Durable Mechanical Circulatory Support	24
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia	21
Forthcoming Issues	21
Changing Landscape of Heart Failure Imaging	21
Therapy-Related Clonal Hematopoiesis	19
Understanding Myocardial Metabolism in the Context of Cardio-Oncology	19
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging	18
Mitral Regurgitation	18
Preload Reduction Therapies in Heart Failure	18
When all Else Fails, Try This	18
Genetics of High-Altitude Pulmonary Edema	17
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now	16
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine	16
Contributors	16
Arrhythmias in Adult Congenital Heart Disease Heart Failure	15
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis	14
Contributors	14
Contributors	14
Hypertension and Heart Failure with Preserved Ejection Fraction	14

Specific Therapy in Transthyretin Amyloid Cardiomyopathy	13
Heart Failure Clinics	13
Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction	12
Myocardial Dysfunction in Patients with Cancer	12
Copyright	12
Emerging Roles for Artificial Intelligence in Heart Failure Imaging	12
Arrythmia-Mediated Valvular Heart Disease	11
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population	10
Advanced Heart Failure in a Special Population	10
Guide to Temporary Mechanical Support in Cardiogenic Shock	10
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure	10
Coronary Angiography in the Evaluation of Systolic Heart Failure	10
Contributors	10
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure	10
SGLT2 Inhibitors in Heart Failure	9
Cardiac Contractility Modulation	9
Cardiac Amyloidosis	9
Application of 3D Printing Technology in Heart Failure	9
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease	9
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging	9
Noncoding RNAs in Pulmonary Arterial Hypertension	9
Contents	8
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis	8
Contributors	8
Disease-modifier Drugs in Patients with Advanced Heart Failure	7
SGLT2 Inhibitors in Type 2 Diabetes Mellitus	7
Preface	7
Copyright	7
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes	7
Inotropes in Patients with Advanced Heart Failure	7
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors	7
Copyright	6
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study	6
Advanced Heart Failure: From Pathophysiology to Clinical Management	6
Aortic Valvular Stenosis and Heart Failure	6
Contents	6
Phenomapping Heart Failure with Preserved Ejection Fraction Using Machine Learning Cluster Analysis	6
Advanced Heart Failure in Special Population	6
Adults with Congenital Heart Disease and Transplant	6
Echocardiography in Advanced Heart Failure for Diagnosis, Management, and Prognosis	6
Contents	6
Sleep Disorder and Heart Failure with Preserved Ejection Fraction	6
Clinical Practice Guidelines in Cardio-Oncology	5
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure	5
Exercise Testing in Pulmonary Hypertension and Heart Failure	5
SGLT2 Inhibitors and Peripheral Vascular Events	5
Contents	5
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy	5
Remote Monitoring Devices and Heart Failure	4
Coronary Microvascular Dysfunction	4

The Risk of Sudden Unexpected Cardiac Death in Children	4
Advances in the Therapy of Light Chain Cardiac Amyloidosis	4
Clinical Phenogroups in Heart Failure with Preserved Ejection Fraction	4
Novel Non-pharmacological Approaches to Heart Failure	4
Contributors	4
Clinical Use of Biomarkers in Cardiac Amyloidosis	4
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease	4
Pathophysiology of Cardiac Amyloidosis	4